567 related articles for article (PubMed ID: 15979033)
21. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
22. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
23. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.
Takeshima Y; Yagi M; Okizuka Y; Awano H; Zhang Z; Yamauchi Y; Nishio H; Matsuo M
J Hum Genet; 2010 Jun; 55(6):379-88. PubMed ID: 20485447
[TBL] [Abstract][Full Text] [Related]
24. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients.
Hofstra RM; Mulder IM; Vossen R; de Koning-Gans PA; Kraak M; Ginjaar IB; van der Hout AH; Bakker E; Buys CH; van Ommen GJ; van Essen AJ; den Dunnen JT
Hum Mutat; 2004 Jan; 23(1):57-66. PubMed ID: 14695533
[TBL] [Abstract][Full Text] [Related]
25. Cloning and sequencing of junction fragment with exons 45-54 deletion of dystrophin gene.
Zhong M; Pan SY; Lu BX; Li W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):138-41. PubMed ID: 16604481
[TBL] [Abstract][Full Text] [Related]
26. A G-to-T transversion at the splice acceptor site of dystrophin exon 14 shows multiple splicing outcomes that are not exemplified by transition mutations.
Ota M; Takeshima Y; Nishida A; Awano H; Lee T; Yagi M; Matsuo M
Genet Test Mol Biomarkers; 2012 Jan; 16(1):3-8. PubMed ID: 21854195
[TBL] [Abstract][Full Text] [Related]
27. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
[TBL] [Abstract][Full Text] [Related]
28. [Comparison and analysis of the molecular character of breakpoints in introns of deletion hotspots of dystrophin gene].
Sheng WL; Chen JY; Pan SY; Zhang C; Liu ZL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):376-80. PubMed ID: 14556187
[TBL] [Abstract][Full Text] [Related]
29. [A novel splice-site mutation in the STA gene in a Japanese patient with Emery-Dreifuss muscular dystrophy].
Hasegawa T; Kobayashi K; Arahata K; Itoyama Y
Rinsho Shinkeigaku; 1999 Nov; 39(11):1138-43. PubMed ID: 10689937
[TBL] [Abstract][Full Text] [Related]
30. Protein truncation test: analysis of two novel point mutations at the carboxy-terminus of the human dystrophin gene associated with mental retardation.
Tuffery S; Lenk U; Roberts RG; Coubes C; Demaille J; Claustres M
Hum Mutat; 1995; 6(2):126-35. PubMed ID: 7581396
[TBL] [Abstract][Full Text] [Related]
31. Point mutations in Czech DMD/BMD patients and their phenotypic outcome.
Sedlácková J; Vondrácek P; Hermanová M; Zámecník J; Hrubá Z; Haberlová J; Kraus J; Maríková T; Hedvicáková P; Vohánka S; Fajkusová L
Neuromuscul Disord; 2009 Nov; 19(11):749-53. PubMed ID: 19783145
[TBL] [Abstract][Full Text] [Related]
32. Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy.
Adachi K; Takeshima Y; Wada H; Yagi M; Nakamura H; Matsuo M
Pediatr Res; 2003 Jan; 53(1):125-31. PubMed ID: 12508091
[TBL] [Abstract][Full Text] [Related]
33. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
[TBL] [Abstract][Full Text] [Related]
34. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
35. Altered mRNA expression due to insertion or substitution of thymine at position +3 of two splice-donor sites in the androgen receptor gene.
Trifiro MA; Lumbroso R; Beitel LK; Vasiliou DM; Bouchard J; Deal C; Van Vliet G; Pinsky L
Eur J Hum Genet; 1997; 5(1):50-8. PubMed ID: 9156321
[TBL] [Abstract][Full Text] [Related]
36. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
37. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.
Hamed S; Sutherland-Smith A; Gorospe J; Kendrick-Jones J; Hoffman E
Clin Genet; 2005 Jul; 68(1):69-79. PubMed ID: 15952989
[TBL] [Abstract][Full Text] [Related]
38. Point mutation and polymorphism in Duchenne/Becker muscular dystrophy (D/BMD) patients.
Chaturvedi LS; Mukherjee M; Srivastava S; Mittal RD; Mittal B
Exp Mol Med; 2001 Dec; 33(4):251-6. PubMed ID: 11795488
[TBL] [Abstract][Full Text] [Related]
39. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
40. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
